E

EuBiologics Co Ltd
KOSDAQ:206650

Watchlist Manager
EuBiologics Co Ltd
KOSDAQ:206650
Watchlist
Price: 11 940 KRW 0.59%
Market Cap: 436.2B KRW
Have any thoughts about
EuBiologics Co Ltd?
Write Note

EuBiologics Co Ltd
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

EuBiologics Co Ltd
Other Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
E
EuBiologics Co Ltd
KOSDAQ:206650
Other Current Liabilities
â‚©14B
CAGR 3-Years
4%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Other Current Liabilities
â‚©430.7B
CAGR 3-Years
-5%
CAGR 5-Years
10%
CAGR 10-Years
18%
SK Bioscience Co Ltd
KRX:302440
Other Current Liabilities
â‚©104.4B
CAGR 3-Years
-9%
CAGR 5-Years
35%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Other Current Liabilities
â‚©42.2B
CAGR 3-Years
16%
CAGR 5-Years
22%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Other Current Liabilities
â‚©25B
CAGR 3-Years
12%
CAGR 5-Years
23%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Other Current Liabilities
â‚©12.2B
CAGR 3-Years
30%
CAGR 5-Years
40%
CAGR 10-Years
N/A
No Stocks Found

EuBiologics Co Ltd
Glance View

Market Cap
435.3B KRW
Industry
Biotechnology

EuBiologics Co., Ltd. engages in the research, development, and manufacture of biopharmaceutical products. The company is headquartered in Seoul, Seoul and currently employs 323 full-time employees. The company went IPO on 2017-01-24. The firm operates its business through two segments. The Vaccine segment manufactures and sells oral cholera vaccines. The Contract Research and Manufacturing Organization (CRMO) segment contracts, researches and manufactures biopharmaceuticals.

Intrinsic Value
17 631.48 KRW
Undervaluation 32%
Intrinsic Value
Price
E

See Also

What is EuBiologics Co Ltd's Other Current Liabilities?
Other Current Liabilities
14B KRW

Based on the financial report for Sep 30, 2024, EuBiologics Co Ltd's Other Current Liabilities amounts to 14B KRW.

What is EuBiologics Co Ltd's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 5Y
4%

Over the last year, the Other Current Liabilities growth was 6%. The average annual Other Current Liabilities growth rates for EuBiologics Co Ltd have been 4% over the past three years , 4% over the past five years .

Back to Top